Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Ruthann Russo
Ruthann Russo is a Managing Director with Berkeley Research Group where she provides Population Health, Integrative Health and Informatics strategies and consulting services to healthcare systems. She is also a faculty member in Saybrook University's Graduate School of Integrative Medicine and Health Services. She earned her PhD in Mind-Body Medicine and is also a licensed, board certified acupuncturist, certified health coach, and yoga teacher.